183 related articles for article (PubMed ID: 26289556)
1. Genomic Profiling Reveals Unique Molecular Alterations in Hepatoblastomas and Adjacent Hepatocellular Carcinomas in B6C3F1 Mice.
Bhusari S; Pandiri AR; Nagai H; Wang Y; Foley J; Hong HH; Ton TV; DeVito M; Shockley KR; Peddada SD; Gerrish KE; Malarkey DE; Hooth MJ; Sills RC; Hoenerhoff MJ
Toxicol Pathol; 2015 Dec; 43(8):1114-26. PubMed ID: 26289556
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas.
Luo JH; Ren B; Keryanov S; Tseng GC; Rao UN; Monga SP; Strom S; Demetris AJ; Nalesnik M; Yu YP; Ranganathan S; Michalopoulos GK
Hepatology; 2006 Oct; 44(4):1012-24. PubMed ID: 17006932
[TBL] [Abstract][Full Text] [Related]
3. The genomic landscape of hepatoblastoma and their progenies with HCC-like features.
Eichenmüller M; Trippel F; Kreuder M; Beck A; Schwarzmayr T; Häberle B; Cairo S; Leuschner I; von Schweinitz D; Strom TM; Kappler R
J Hepatol; 2014 Dec; 61(6):1312-20. PubMed ID: 25135868
[TBL] [Abstract][Full Text] [Related]
4. Tissue microarray immunohistochemical profiles of p53 and pRB in hepatocellular carcinoma and hepatoblastoma.
Azlin AH; Looi LM; Cheah PL
Asian Pac J Cancer Prev; 2014; 15(9):3959-63. PubMed ID: 24935581
[TBL] [Abstract][Full Text] [Related]
5. Quantification of glypican 3, β-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution.
Zhou S; Parham DM; Yung E; Pattengale P; Wang L
Histopathology; 2015 Dec; 67(6):905-13. PubMed ID: 25939253
[TBL] [Abstract][Full Text] [Related]
6. Hepatic progenitor cells in liver cancers from Asian children.
Ward SC; Thung SN; Lim KH; Tran TT; Hong TK; Hoang PL; Jang JJ; Park YN; Abe K
Liver Int; 2010 Jan; 30(1):102-11. PubMed ID: 19793197
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects.
Buendia MA
Med Pediatr Oncol; 2002 Nov; 39(5):530-5. PubMed ID: 12228912
[TBL] [Abstract][Full Text] [Related]
8. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
[TBL] [Abstract][Full Text] [Related]
9. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of multidrug resistance genes MDR1 and cMOAT in human hepatocellular carcinoma and hepatoblastoma cell lines.
Minemura M; Tanimura H; Tabor E
Int J Oncol; 1999 Sep; 15(3):559-63. PubMed ID: 10427140
[TBL] [Abstract][Full Text] [Related]
11. Expression ratio of hepatocyte nuclear factor-1 to variant hepatocyte nuclear factor-1 in differentiation of hepatocellular carcinoma and hepatoblastoma.
Ninomiya T; Hayashi Y; Saijoh K; Ohta K; Yoon S; Nakabayashi H; Tamaoki T; Kasuga M; Itoh H
J Hepatol; 1996 Oct; 25(4):445-53. PubMed ID: 8912143
[TBL] [Abstract][Full Text] [Related]
12. Global gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancer.
Hoenerhoff MJ; Pandiri AR; Lahousse SA; Hong HH; Ton TV; Masinde T; Auerbach SS; Gerrish K; Bushel PR; Shockley KR; Peddada SD; Sills RC
Toxicol Pathol; 2011 Jun; 39(4):678-99. PubMed ID: 21571946
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam.
Anna CH; Sills RC; Foley JF; Stockton PS; Ton TV; Devereux TR
Cancer Res; 2000 Jun; 60(11):2864-8. PubMed ID: 10850429
[TBL] [Abstract][Full Text] [Related]
14. Integrative genomic analysis of mouse and human hepatocellular carcinoma.
Dow M; Pyke RM; Tsui BY; Alexandrov LB; Nakagawa H; Taniguchi K; Seki E; Harismendy O; Shalapour S; Karin M; Carter H; Font-Burgada J
Proc Natl Acad Sci U S A; 2018 Oct; 115(42):E9879-E9888. PubMed ID: 30287485
[TBL] [Abstract][Full Text] [Related]
15. Proliferating EpCAM-Positive Ductal Cells in the Inflamed Liver Give Rise to Hepatocellular Carcinoma.
Matsumoto T; Takai A; Eso Y; Kinoshita K; Manabe T; Seno H; Chiba T; Marusawa H
Cancer Res; 2017 Nov; 77(22):6131-6143. PubMed ID: 28951464
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of a novel imprinted gene, PEG10, in human hepatocellular carcinoma and in regenerating mouse livers.
Tsou AP; Chuang YC; Su JY; Yang CW; Liao YL; Liu WK; Chiu JH; Chou CK
J Biomed Sci; 2003; 10(6 Pt 1):625-35. PubMed ID: 14576465
[TBL] [Abstract][Full Text] [Related]
17. Comparative and integrative functional genomics of HCC.
Lee JS; Thorgeirsson SS
Oncogene; 2006 Jun; 25(27):3801-9. PubMed ID: 16799621
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
[TBL] [Abstract][Full Text] [Related]
19. Identification and experimental validation of druggable epigenetic targets in hepatoblastoma.
Clavería-Cabello A; Herranz JM; Latasa MU; Arechederra M; Uriarte I; Pineda-Lucena A; Prosper F; Berraondo P; Alonso C; Sangro B; García Marin JJ; Martinez-Chantar ML; Ciordia S; Corrales FJ; Francalanci P; Alaggio R; Zucman-Rossi J; Indersie E; Cairo S; Domingo-Sàbat M; Zanatto L; Sancho-Bru P; Armengol C; Berasain C; Fernandez-Barrena MG; Avila MA
J Hepatol; 2023 Oct; 79(4):989-1005. PubMed ID: 37302584
[TBL] [Abstract][Full Text] [Related]
20. Use of a rainbow trout oligonucleotide microarray to determine transcriptional patterns in aflatoxin B1-induced hepatocellular carcinoma compared to adjacent liver.
Tilton SC; Gerwick LG; Hendricks JD; Rosato CS; Corley-Smith G; Givan SA; Bailey GS; Bayne CJ; Williams DE
Toxicol Sci; 2005 Dec; 88(2):319-30. PubMed ID: 16141433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
